focus -WSS

focus

author：focus 2025-09-28 01:31:54 - browse：854

Adobe

Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for its video game that improves symptoms of ADHD in children, on Wednesday announced it would reorient its business around selling its products directly to users over the counter, rather than by prescription.

In connection with the move away from prescription sales, Akili will reduce its workforce by 40%, which the company projects will extend its runway into the second half of 2025. The Boston-based company will continue offering its pediatric treatment, EndeavorRx, by prescription until it can convert it to over-the-counter labeling — it plans to submit data to FDA in 2024.

Akili went public last year and though its prescription sales were slowly increasing, the company’s costs far outstripped its revenues. In its second-quarter results reported in August, Akili said it earned just $114,000 on $15.3 million in expenses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Despite FDA concern, risk that CAR

WSS

Chimpanzees, like humans and whales, get menopause: Study

The FDA weighs the risks of candy

First Opinion Podcast: How to protect health care in times of war

Diagnostic tests are hitting their mathematical limits

With clinical trial data readouts, here's how to spot spin

CDC recommends rationing of RSV shot due to shortages

Wikipedia

focus

leisure time

Medicare details structure of new drug price negotiation program

Hospitals warn Medicare's drug payment fix is ‘unlawful’

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

First Opinion Podcast: How to protect health care in times of war

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA investigates CAR

Affirmative action in medical school literally saved lives

FDA investigates CAR

What does generative AI mean for health care? We asked experts

Diagnostic tests are hitting their mathematical limits

leisure time

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

UnitedHealth’s Optum accused of antitrust violations in California

30 years of 'Listening to Prozac'

Readout Newsletter: What happened with Sarepta's Duchenne data

Emergency medicine has repudiated 'excited delirium.' Now what?

The pink breast cancer awareness ribbon needs a redesign

explore

hotspot

hotspot

hotspot